Healthcare Contract Manufacturing Market by Service Type, Product Type, Molecule Type, Therapeutic Area, End User, Company Size

The healthcare contract manufacturing market is evolving rapidly, shaped by technological advancement, stricter compliance expectations, and the demand for swift, reliable partnerships across the pharmaceutical sector. As innovation reshapes how life sciences organizations approach outsourcing, industry dynamics continue to drive the adoption of integrated, quality-focused solutions at scale.

Market Snapshot: Healthcare Contract Manufacturing

The Healthcare Contract Manufacturing Market grew from USD 201.68 billion in 2024 to USD 219.70 billion in 2025. It is expected to continue growing at a CAGR of 8.52%, reaching USD 329.52 billion by 2030. Sector growth reflects heightened demand for specialized manufacturing expertise, driven by new therapeutic modalities, stricter regulatory landscapes, and increased outsourcing by pharmaceutical and biotech firms. Strategic partnerships now extend across the full product lifecycle, reinforcing agility in both R&D and commercial delivery.

Scope & Segmentation

Service Types: Analytical testing (chemical, microbiological, stability); API manufacturing (biotech and synthetic); biologics manufacturing (monoclonal antibodies, recombinant proteins, vaccines); clinical trial manufacturing (Phase I, II, III); fill-finish; formulation development (liquid, semi-solid, solid dosage).
Product Types: Biologics; liquid dosage forms (emulsions, solutions, suspensions); solid dosage forms (capsules, granules, tablets); sterile injectable options (prefilled syringes, vials).
Molecule Types: Biologics, biosimilars, complex peptides, small molecules.
Therapeutic Areas: Cardiovascular; central nervous system; infectious disease; oncology, further segmented into hematological malignancies and solid tumors.
End Users: Biotech companies, CROs, pharmaceutical companies, research institutions.
Company Size: Large enterprises, mid-sized enterprises, small enterprises.
Geographies: Americas (including U.S. regions such as California, Texas, New York), Canada, Mexico, Brazil, Argentina; Europe, Middle East & Africa (including UK, Germany, France, Russia, and others); Asia-Pacific (China, India, Japan, Australia, Korea, Southeast Asia markets).
Key Companies: Lonza Group AG, Catalent, Inc., Thermo Fisher Scientific Inc., WuXi AppTec Co., Ltd., Samsung Biologics Co., Ltd., Boehringer Ingelheim International GmbH, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Recipharm AB, Siegfried Holding AG, Aenova Holding GmbH.

Key Takeaways for Senior Decision-Makers

Contract manufacturers have expanded from basic outsourcing to delivering integrated, end-to-end solutions combining quality, compliance, and operational scale.
Adoption of digital platforms and data analytics is enabling more efficient process control, batch consistency, and accelerated timelines for regulatory review.
Specialized expertise in biologics manufacturing is becoming critical as the pipeline for monoclonal antibodies, recombinant proteins, and vaccines grows more diverse.
Supply chain strategies increasingly focus on resilience: nearshoring, multi-sourcing, and investment in sustainable production to address regulatory and environmental pressures.
Mid-tier and regional service providers differentiate through agility, targeted partnerships, and niche technical capabilities aligned with emerging therapies and novel drug classes.

Tariff Impact: Navigating Recent Trade Policies

New tariff regimes have led to substantial changes in the sourcing of raw materials and active pharmaceutical ingredients. Organizations are responding by optimizing supplier agreements, shifting production footprints, and assessing regional cost structures. North America leverages nearshoring to reduce lead times, while Asia-Pacific continues to invest in local capacity despite cost fluctuations, and EMEA utilizes trade agreements for strategic chemical access. Margin management and proactive tariff modeling have become vital to sustaining operational flexibility and profitability.

Methodology & Data Sources

This report uses a rigorous mixed-method approach, combining primary interviews with industry and regulatory leaders, analysis of regulatory filings, whitepapers, and peer-reviewed studies. Quantitative insights come from proprietary databases, capacity and expenditure tracking, and clinical pipeline data, supported by segmentation methodologies that ensure consistency and accuracy across service lines and geographic markets.

Why This Report Matters

Enables senior stakeholders to benchmark new service models and digital advancements against best-in-class industry practices.
Delivers actionable insights to inform strategic planning for operational investments, supplier diversification, and risk management across global markets.
Supports informed decision-making amid complex regulatory, technological, and geopolitical business environments.

Conclusion

The healthcare contract manufacturing sector is positioned for continued advancement, with growth shaped by collaboration, technology adoption, and strategic adaptability. Leaders who align with these evolving priorities will capture new opportunities and sustain competitive advantage.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Healthcare Contract Manufacturing Market, by Service Type

8.1. Introduction
8.2. Analytical Testing
8.2.1. Chemical Testing
8.2.2. Microbiological Testing
8.2.3. Stability Testing
8.3. Api Manufacturing
8.3.1. Biotech API
8.3.2. Synthetic API
8.4. Biologics Manufacturing
8.4.1. Monoclonal Antibodies
8.4.2. Recombinant Proteins
8.4.3. Vaccines
8.5. Clinical Trial Manufacturing
8.5.1. Phase I
8.5.2. Phase II
8.5.3. Phase III
8.6. Fill Finish
8.7. Formulation Development
8.7.1. Liquid Dosage
8.7.2. Semi Solid Dosage
8.7.3. Solid Dosage

9. Healthcare Contract Manufacturing Market, by Product Type

9.1. Introduction
9.2. Biologics
9.3. Liquid Dosage
9.3.1. Emulsions
9.3.2. Solutions
9.3.3. Suspensions
9.4. Solid Dosage
9.4.1. Capsules
9.4.2. Granules
9.4.3. Tablets
9.5. Sterile Injectable
9.5.1. Prefilled Syringes
9.5.2. Vials

10. Healthcare Contract Manufacturing Market, by Molecule Type

10.1. Introduction
10.2. Biologics
10.3. Biosimilars
10.4. Complex Peptides
10.5. Small Molecules

11. Healthcare Contract Manufacturing Market, by Therapeutic Area

11.1. Introduction
11.2. Cardiovascular
11.3. Central Nervous System
11.4. Infectious Disease
11.5. Oncology
11.5.1. Hematological Malignancies
11.5.2. Solid Tumors

12. Healthcare Contract Manufacturing Market, by End User

12.1. Introduction
12.2. Biotech Companies
12.3. Cros
12.4. Pharmaceutical Companies
12.5. Research Institutions

13. Healthcare Contract Manufacturing Market, by Company Size

13.1. Introduction
13.2. Large Enterprises
13.3. Mid-Sized Enterprises
13.4. Small Enterprises

14. Americas Healthcare Contract Manufacturing Market

14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa Healthcare Contract Manufacturing Market

15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific Healthcare Contract Manufacturing Market

16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape

17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Lonza Group AG
17.3.2. Catalent, Inc.
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. WuXi AppTec Co., Ltd.
17.3.5. Samsung Biologics Co., Ltd.
17.3.6. Boehringer Ingelheim International GmbH
17.3.7. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
17.3.8. Recipharm AB
17.3.9. Siegfried Holding AG
17.3.10. Aenova Holding GmbH

18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix

List of Figures

FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET MULTI-CURRENCY
FIGURE 2. HEALTHCARE CONTRACT MANUFACTURING MARKET MULTI-LANGUAGE
FIGURE 3. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024

List of Tables

TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CHEMICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECH API, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SYNTHETIC API, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FILL FINISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPLEX PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MID-SIZED ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SMALL ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 103. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 104. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 105. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 106. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 107. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 108. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 110. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 111. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 112. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 114. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 119. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 120. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 121. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 122. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 123. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 129. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 195. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 196. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 197. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 198. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 199. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 202. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 203. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 205. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 209. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 210. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 211. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 212. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 213. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 214. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 216. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 217. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 218. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 219. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 220. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 221. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 238. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 239. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 240. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 241. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 242. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 243. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 244. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 246. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 247. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 248. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 249. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 250. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 251. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 254. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 255. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 256. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 257. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 258. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 259. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 261. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 262. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 263. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 265. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZ

Samples

Sample File

DOWNLOAD NOW

Companies Mentioned

The companies profiled in this Healthcare Contract Manufacturing market report include:

Lonza Group AG
Catalent, Inc.
Thermo Fisher Scientific Inc.
WuXi AppTec Co., Ltd.
Samsung Biologics Co., Ltd.
Boehringer Ingelheim International GmbH
Fujifilm Diosynth Biotechnologies U.S.A., Inc.
Recipharm AB
Siegfried Holding AG
Aenova Holding GmbH

Table Information

Report Attribute	Details
No. of Pages	182
Published	May 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 219.7 Billion
Forecasted Market Value ( USD ) by 2030	$ 329.52 Billion
Compound Annual Growth Rate	8.5%
Regions Covered	Global
No. of Companies Mentioned	11

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3135EUR$3,545USD£2,674GBP €3483EUR$3,939USD£2,971GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3381EUR$3,824USD£2,885GBP €3757EUR$4,249USD£3,205GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4583EUR$5,183USD£3,910GBP €5092EUR$5,759USD£4,344GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5546EUR$6,272USD£4,731GBP €6162EUR$6,969USD£5,257GBP

Healthcare Contract Manufacturing Market by Service Type, Product Type, Molecule Type, Therapeutic Area, End User, Company Size - Global Forecast to 2030

Market Snapshot: Healthcare Contract Manufacturing

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating Recent Trade Policies

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Market Snapshot: Healthcare Contract Manufacturing

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating Recent Trade Policies

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Medical Device Contract Manufacturing Market by Type, Service Type, Device Class, Manufacturing Process, End-User - Global Forecast to 2030

Medical Device Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Class I, Class II, Class III), By Services, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Medical Device Contract Manufacturing - Global Strategic Business Report

Medical Device Contract Manufacturing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)